搜索临床试验以:白蛋白结合紫杉醇加 SHR-1210(PD-1 抑制剂)
总计672个结果
-
Guangdong Association of Clinical Trials尚未招聘
-
Sun Yat-sen UniversityShanghai Junshi Bioscience Co., Ltd.; CSPC Ouyi Pharmaceutical Co., Ltd.招聘中
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals; Sai Life Sciences完全的
-
Tianjin Medical University Cancer Institute and...尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.暂停
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Peking University First HospitalMerck Sharp & Dohme LLC尚未招聘
-
Chinese PLA General Hospital未知
-
Emory UniversityNational Cancer Institute (NCI)主动,不招人
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Shandong Cancer Hospital and Institute未知
-
Taipei Veterans General Hospital, Taiwan完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
M.D. Anderson Cancer Center招聘中恶性实体肿瘤 | 转移性肾细胞癌 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 晚期肝细胞癌 | III 期肾细胞癌 AJCC v8 | IV 期肾细胞癌 AJCC v8 | III 期子宫体癌 AJCC v8 | IV 期子宫体癌 AJCC v8 | IVA 期子宫体癌... 及其他条件美国
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
The First Affiliated Hospital of Zhengzhou UniversityJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; National Cheng-Kung University Hospital完全的
-
OHSU Knight Cancer InstituteOregon Health and Science University尚未招聘II 期胰腺癌 AJCC v8 | III 期胰腺癌 AJCC v8 | IV 期胰腺癌 AJCC v8 | 转移性胰腺导管腺癌 | 局部晚期胰腺导管腺癌 | 不可切除的胰腺癌美国
-
Boehringer Ingelheim完全的卵巢肿瘤 | 腹膜肿瘤美国, 澳大利亚, 奥地利, 比利时, 加拿大, 捷克语, 丹麦, 芬兰, 法国, 德国, 希腊, 意大利, 荷兰, 挪威, 波兰, 葡萄牙, 俄罗斯联邦, 斯洛伐克, 西班牙, 瑞典, 乌克兰, 英国
-
The First Affiliated Hospital of Xiamen University招聘中
-
Qilu Hospital of Shandong University招聘中